Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Hexner

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Blood|September 28, 2010
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host diseaseYi Zhang, Ashley R Sandy, Jina Wang, et al.
Blood|March 2, 2017
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in miceQingrong Huang, Shan He, Yuanyuan Tian, et al.
The Journal of Allergy and Clinical Immunology|May 22, 2020
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosisKarin Hartmann, Jason Gotlib, Cem Akin, et al.
The Journal of Clinical Investigation|October 22, 2020
Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance inductionYuanyuan Tian, Lijun Meng, Ying Wang, et al.
The New England Journal of Medicine|June 30, 2016
Efficacy and Safety of Midostaurin in Advanced Systemic MastocytosisJason Gotlib, Hanneke C Kluin-Nelemans, Tracy I George, et al.
European Journal of Haematology|December 27, 2024
Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based RegimenMargaret Rowe, Daria Babushok, Martin Carroll, et al.
Blood Advances|December 20, 2018
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasmsRaajit K Rampal, John O Mascarenhas, Heidi E Kosiorek, et al.
The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.
Research Square|July 10, 2026
HIV-specific and resistant CAR T cells promote control of HIV replication in people with HIVJames Riley, Pablo Tebas, Julie Jadlowsky, et al.
British Journal of Haematology|March 14, 2013
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosisSrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Blood|September 28, 2010
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host diseaseYi Zhang, Ashley R Sandy, Jina Wang, et al.
Blood|March 2, 2017
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in miceQingrong Huang, Shan He, Yuanyuan Tian, et al.
The Journal of Allergy and Clinical Immunology|May 22, 2020
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosisKarin Hartmann, Jason Gotlib, Cem Akin, et al.
The Journal of Clinical Investigation|October 22, 2020
Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance inductionYuanyuan Tian, Lijun Meng, Ying Wang, et al.
The New England Journal of Medicine|June 30, 2016
Efficacy and Safety of Midostaurin in Advanced Systemic MastocytosisJason Gotlib, Hanneke C Kluin-Nelemans, Tracy I George, et al.
European Journal of Haematology|December 27, 2024
Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based RegimenMargaret Rowe, Daria Babushok, Martin Carroll, et al.
Blood Advances|December 20, 2018
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasmsRaajit K Rampal, John O Mascarenhas, Heidi E Kosiorek, et al.
The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.
Research Square|July 10, 2026
HIV-specific and resistant CAR T cells promote control of HIV replication in people with HIVJames Riley, Pablo Tebas, Julie Jadlowsky, et al.
British Journal of Haematology|March 14, 2013
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosisSrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Pageof 6